Petter has over 20 years of life science experience in various roles within business development, licensing, alliance management, sales, procurement and outsourcing management. Currently, at BioArctic AB as Senior Director Business Development, he is responsible for BioArctic' partnering initiatives for the existing pipeline projects as well as new applications for the proprietary technology platform, the BrainTransporter™. Most recently the license agreement with Bristol Myers Squibb for the next generation of AD therapeutics combining a highly selective antibody with BioArctic's BrainTransporter™ technology and the option, collaboration and license agreement with Novartis combining their proprietary antibody for an undisclosed target in neurodegeneration with BioArctic's BrainTransporter™ technology.